Current position:Home >Product >
N-[4-(acetylamino)phenyl]-3-(2-hydroxy-3,4-dimethylphenyl)-1H-pyrazole-5-carboxamide
N-[4-(acetylamino)phenyl]-3-(2-hydroxy-3,4-dimethylphenyl)-1H-pyrazole-5-carboxamide(1095941-38-0)
- Name: N-[4-(acetylamino)phenyl]-3-(2-hydroxy-3,4-dimethylphenyl)-1H-pyrazole-5-carboxamide
- Synonyms:MLS001216410;SMR000544181;CHEMBL1491300;BDBM61739;cid_5625527;DTXSID701320719;HMS2867F15;STK911847;AKOS002264577;N-(4-acetamidophenyl)-3-(2-hydroxy-3,4-dimethylphenyl)-1H-pyrazole-5-carboxamide;N-[4-(acetylamino)phenyl]-3-(2-hydroxy-3,4-dimethylphenyl)-1H-pyrazole-5-carboxamide;(5E)-N-(4-acetamidophenyl)-5-(4,5-dimethyl-6-oxidanylidene-cyclohexa-2,4-dien-1-ylidene)-1,2-dihydropyrazole-3-carboxamide;(5E)-N-(4-acetamidophenyl)-5-(4,5-dimethyl-6-oxo-1-cyclohexa-2,4-dienylidene)-1,2-dihydropyrazole-3-carboxamide;(5E)-N-(4-acetamidophenyl)-5-(6-keto-4,5-dimethyl-cyclohexa-2,4-dien-1-ylidene)-3-pyrazoline-3-carboxamide
- Molecular Formula:C20H20N4O3
- Molecular Weight:364.4
- CAS Registry Number:1095941-38-0
- EINECS:
- Melting Point:
- Water Solubility:0.3 [ug/mL] (The mean of the results at pH 7.4)
Other Product
- 825610-72-8/2-[[5-(2-methylfuran-3-yl)-1,3,4-oxadiazol-2-yl]sulfanyl]-N-pyridin-2-ylacetamide
- 848753-22-0/2-amino-1-(4-butylphenyl)-N-[2-(cyclohex-1-en-1-yl)ethyl]-1H-pyrrolo[2,3-b]quinoxaline-3-carboxamide
- 896596-70-6/3-[2-(cyclohexen-1-yl)ethyl]-8-ethoxy-5H-pyrimido[5,4-b]indol-4-one
- 227094-36-2/methyl {[3-(2,3-dihydro-1,4-benzodioxin-6-yl)-4-oxo-4H-chromen-7-yl]oxy}acetate
- 879429-59-1/3-(5-tert-butyl-1H-pyrazol-3-yl)-4-(2-fluorophenyl)-1H-1,2,4-triazole-5-thione
- 878981-34-1/3-[3-(3,4-Diethoxyphenyl)-1,2,4-oxadiazol-5-yl]pyridine
- 675131-44-9/3-(Cinnamylthio)-5-(2,4-dichlorophenyl)-4H-1,2,4-triazol-4-amine
- 562087-37-0/N-(2,5-dimethylphenyl)-2-{[4-ethyl-5-(thiophen-2-yl)-4H-1,2,4-triazol-3-yl]sulfanyl}acetamide
- 573698-19-8/N-[4-(benzyloxy)phenyl]-2-{[5-(furan-2-yl)-4-(prop-2-en-1-yl)-4H-1,2,4-triazol-3-yl]sulfanyl}acetamide
- 573698-36-9/2-{[4-Allyl-5-(2-furyl)-4H-1,2,4-triazol-3-YL]sulfanyl}-N-(2-methoxydibenzo[B,D]furan-3-YL)acetamide
- 573704-97-9/2-((4-Amino-5-(3,4,5-trimethoxyphenyl)-4H-1,2,4-triazol-3-yl)thio)acetamide
- 558429-54-2/2-{[4-ethyl-5-(thiophen-2-yl)-4H-1,2,4-triazol-3-yl]sulfanyl}-N-(4-phenoxyphenyl)acetamide
- 573705-53-0/N-(2-tert-butylphenyl)-2-{[4-ethyl-5-(pyridin-3-yl)-4H-1,2,4-triazol-3-yl]sulfanyl}acetamide
- 565446-72-2/2-{[4-ethyl-5-(thiophen-2-yl)-4H-1,2,4-triazol-3-yl]sulfanyl}-N-(4-sulfamoylphenyl)acetamide
- 618879-84-8/N-[4-chloro-3-(trifluoromethyl)phenyl]-2-{[4-(prop-2-en-1-yl)-5-(thiophen-2-yl)-4H-1,2,4-triazol-3-yl]sulfanyl}acetamide
- 618432-12-5/2-[(3-bromobenzyl)sulfanyl]-3-(4-chlorophenyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one
- 675842-04-3/3-(Cinnamylthio)-5-(3-pyridinyl)-4H-1,2,4-triazol-4-amine
- 618415-18-2/N-(2-bromo-4,6-difluorophenyl)-2-{[4-ethyl-5-(pyridin-2-yl)-4H-1,2,4-triazol-3-yl]sulfanyl}acetamide
- 347910-13-8/2-[[5-(4-Bromophenyl)-4-methyl-4H-1,2,4-triazol-3-yl]thio]acetic acid 2-[(3,4-dimethoxyphenyl)methylene]hydrazide
- 1095941-38-0/N-[4-(acetylamino)phenyl]-3-(2-hydroxy-3,4-dimethylphenyl)-1H-pyrazole-5-carboxamide
- 879450-96-1/3-[(4-methylphenoxy)methyl]-4-(4-methylphenyl)-5-[(4-nitrobenzyl)sulfanyl]-4H-1,2,4-triazole
- 883956-33-0/3-Butyl-2-thiophen-2-ylchromeno[2,3-d]pyrimidine-4,5-dione
- 635700-03-7/Methyl 7-bromo-5-(2-chlorophenyl)-2,3-dihydro-2-thioxo-1H-1,4-benzodiazepine-1-acetate
- 879456-96-9/4-(3-chloro-4-fluorophenyl)-3-(5-cyclopropyl-1H-pyrazol-3-yl)-1H-1,2,4-triazole-5-thione
- 896598-42-8/6-chloro-2-[(4-methoxyphenyl)methylamino]-5-methyl-1H-[1,2,4]triazolo[1,5-a]pyrimidin-7-one
- 896592-65-7/3-Phenyl-2-propylchromeno[2,3-d]pyrimidine-4,5-dione
- 879457-90-6/N-(3,4-dimethylphenyl)-3-(2-hydroxy-4,5-dimethylphenyl)-1H-pyrazole-5-carboxamide
- 474312-03-3/N-(4-acetylphenyl)-4-benzylpiperidine-1-carbothioamide
- 879767-92-7/2-Ethyl-3-[(4-methoxyphenyl)methyl]thiochromeno[2,3-d]pyrimidine-4,5-dione
- 879435-49-1/4-(4-(2-methoxyphenyl)-5-(trifluoromethyl)-1H-pyrazol-3-yl)benzene-1,3-diol